What's Happening?

During the COVID-19 pandemic, digital tools allowed pathologists to work remotely, integrating digital diagnostics into everyday clinical care. However, recent regulatory guidance is now restricting the continued use of these digital practices, which were initially enabled by temporary regulatory flexibility. This shift has raised concerns about how legacy oversight can impede modern clinical practices that have proven effective during the pandemic.

Why It's Important?

The restrictions on digital medicine highlight the tension between traditional regulatory frameworks and the evolving needs of modern healthcare. The ability to work remotely has improved access to specialized care and increased resilience in the healthcare workforce. Limiting these practices could reverse these gains, affecting patient care and the efficiency of healthcare delivery. The situation underscores the need for regulatory bodies to adapt to technological advancements in medicine.

AI Generated Content

For the benefit of users - Parts of this article may include content generated using AI tools. Our teams are making active and commercially reasonable efforts to moderate all AI generated content. Our moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. We encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. We maintain that all AI generated content on our platform is for entertainment purposes only. To know more about how we use AI, you can write to us at

Close AI Generated Content